Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1881 1
1882 1
1891 1
1895 5
1896 1
1898 1
1917 1
1918 1
1919 1
1920 1
1922 2
1964 1
1967 3
1968 3
1969 1
1970 5
1971 4
1972 4
1974 1
1976 1
1977 2
1978 4
1979 3
1980 1
1982 6
1983 1
1984 1
1985 6
1986 12
1987 8
1988 13
1989 12
1990 11
1991 16
1992 5
1993 17
1994 20
1995 15
1996 13
1997 15
1998 11
1999 14
2000 26
2001 21
2002 12
2003 18
2004 20
2005 35
2006 25
2007 29
2008 45
2009 36
2010 46
2011 57
2012 59
2013 64
2014 55
2015 35
2016 43
2017 32
2018 35
2019 53
2020 93
2021 125
2022 106
2023 77
2024 68

Text availability

Article attribute

Article type

Publication date

Search Results

1,296 results

Results by year

Filters applied: . Clear all
Page 1
Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled Trial.
Kwan ATH, Lakhani M, Le GH, Singh G, Teopiz KM, Ceban F, Nijjar CS, Meshkat S, Badulescu S, Ho R, Rhee TG, Di Vincenzo JD, Gill H, McIntyre RS. Kwan ATH, et al. Among authors: gill h. Eur Arch Psychiatry Clin Neurosci. 2024 Aug 27. doi: 10.1007/s00406-024-01877-x. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39190040
Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy.
Banks E, Francis V, Lin SJ, Kharfallah F, Fonov V, Lévesque M, Han C, Kulasekaran G, Tuznik M, Bayati A, Al-Khater R, Alkuraya FS, Argyriou L, Babaei M, Bahlo M, Bakhshoodeh B, Barr E, Bartik L, Bassiony M, Bertrand M, Braun D, Buchert R, Budetta M, Cadieux-Dion M, Calame DG, Cope H, Cushing D, Efthymiou S, Elmaksoud MA, El Said HG, Froukh T, Gill HK, Gleeson JG, Gogoll L, Goh ES, Gowda VK, Haack TB, Hashem MO, Hauser S, Hoffman TL, Hogue JS, Hosokawa A, Houlden H, Huang K, Huynh S, Karimiani EG, Kaulfuß S, Korenke GC, Kritzer A, Lee H, Lupski JR, Marco EJ, McWalter K, Minassian A, Minassian BA, Murphy D, Neira-Fresneda J, Northrup H, Nyaga DM, Oehl-Jaschkowitz B, Osmond M, Person R, Pehlivan D, Petree C, Sadleir LG, Saunders C, Schoels L, Shashi V, Spillmann RC, Srinivasan VM, Torbati PN, Tos T; Undiagnosed Diseases Network; Zaki MS, Zhou D, Zweier C, Trempe JF, Durcan TM, Gan-Or Z, Avoli M, Alves C, Varshney GK, Maroofian R, Rudko DA, McPherson PS. Banks E, et al. Among authors: gill hk. Nat Commun. 2024 Aug 22;15(1):7239. doi: 10.1038/s41467-024-51310-z. Nat Commun. 2024. PMID: 39174524 Free PMC article.
Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis.
Le GH, Wong S, Haikazian S, Johnson DE, Badulescu S, Kwan ATH, Gill H, Di Vincenzo JD, Rosenblat JD, Mansur R, Teopiz KM, Rhee TG, Ho R, Liao S, Cao B, Schweinfurth-Keck N, Vinberg M, Grande I, Phan L, d'Andrea G, McIntyre RS. Le GH, et al. Among authors: gill h. J Affect Disord. 2024 Nov 15;365:381-399. doi: 10.1016/j.jad.2024.08.057. Epub 2024 Aug 19. J Affect Disord. 2024. PMID: 39168166 Review.
Performance Optimization and Injury Mitigation for Air Force Student Fighter Pilots.
Chayrez SE, Acevedo A, Blake J, Parrott C, Gerking T, Guthmann D, Jilek M, Dorcheus J, Zeigler Z, Copeland C, Gill H, Smietana A, Price-Moore C, Nores B, Scott RM. Chayrez SE, et al. Among authors: gill h. Mil Med. 2024 Aug 19;189(Supplement_3):465-470. doi: 10.1093/milmed/usae153. Mil Med. 2024. PMID: 39160875
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.
Abu-Zeinah G, Qin A, Gill H, Komatsu N, Mascarenhas J, Shih WJ, Zagrijtschuk O, Sato T, Shimoda K, Silver RT, Mesa R. Abu-Zeinah G, et al. Among authors: gill h. Ann Hematol. 2024 Sep;103(9):3573-3583. doi: 10.1007/s00277-024-05912-8. Epub 2024 Aug 15. Ann Hematol. 2024. PMID: 39145781 Free PMC article. Clinical Trial.
1,296 results